Situation profile

Atopic dermatitis: severe symptoms after standard treatment

This is a composite decision situation, not a real patient, testimonial or individual treatment recommendation.

Atopic dermatitis: severe symptoms after standard treatment

Flares continue despite careful skin care and previous prescriptions, and regenerative advertising reframes eczema as damaged tissue that can be reset. The evidence question is narrower: has the proposed product been tested for atopic dermatitis, against an appropriate comparator, with validated itch and severity outcomes?

What the data says for this situation

Registry snapshot (2026-08-29): MSC studies: 5 (0 recruiting) · HSCT-family: 0 · exosomes: 3. Source: ClinicalTrials.gov API v2.

The stored registry snapshot shows a small research footprint and no recruiting MSC record at retrieval. That makes product-specific documentation more important, not less. Cosmetic exosome or conditioned-media studies cannot be transferred to systemic inflammatory disease.

Questions worth asking any provider

  1. Is my diagnosis and severity documented with a validated scale?
  2. Was this exact product studied for atopic dermatitis rather than cosmetic skin quality?
  3. What established options remain untried or could continue alongside research?
  4. How are infection, allergy and flare risks monitored?

Red flags specific to this situation

  • Cosmetic before-and-after photographs presented as eczema evidence
  • One skin-regeneration protocol sold for eczema, psoriasis and ageing
  • Advice to stop prescribed treatment before an independent dermatology review

Cost context

Compare the full proposed course with the cost and monitoring burden of established dermatology pathways. Do not compare a cosmetic session price with a medical treatment plan.

FAQ

Are exosome facials evidence for atopic dermatitis?

No. Cosmetic skin endpoints and atopic-dermatitis outcomes are different questions.

What does zero recruiting MSC activity mean?

Only that the stored query found no recruiting MSC record on that date; it is not a prognosis or a verdict on all research.

→ Build questions for a specific provider · → Cost calculator

Interactive/editorial page by the StemCellAtlas research team. Where registry or literature counts appear, they use the dated 2026-08-29 snapshot. Browser-only tools do not send or store answers. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads